公开(公告)号：US11267821B2

公开(公告)日：2022-03-08

申请号：US16807335

申请日：2020-03-03

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Yoshiaki Ohashi ,  Yoshihiko Norimine ,  Tamaki Hoshikawa ,  Yu Yoshida ,  Yoshihisa Kobayashi ,  Nobuhiro Sato ,  Koji Hagiwara ,  Nobuaki Sato ,  Shinsuke Hirota ,  Takaaki Harada ,  Hikaru Yoshimura

IPC: C07D495/22 ,  A61K31/551 ,  A61P25/00 ,  C07D491/22 ,  C07D491/147

Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:

公开(公告)号：US11358972B2

公开(公告)日：2022-06-14

申请号：US16807335

申请日：2020-03-03

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Yoshiaki Ohashi ,  Yoshihiko Norimine ,  Tamaki Hoshikawa ,  Yu Yoshida ,  Yoshihisa Kobayashi ,  Nobuhiro Sato ,  Koji Hagiwara ,  Nobuaki Sato ,  Shinsuke Hirota ,  Takaaki Harada ,  Hikaru Yoshimura

IPC: C07D495/22 ,  A61K31/551 ,  A61P25/00 ,  C07D491/22 ,  C07D491/147

Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:

公开(公告)号：US20200283452A1

公开(公告)日：2020-09-10

申请号：US16807335

申请日：2020-03-03

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Yoshiaki Ohashi ,  Yoshihiko Norimine ,  Tamaki Hoshikawa ,  Yu Yoshida ,  Yoshihisa Kobayashi ,  Nobuhiro Sato ,  Koji Hagiwara ,  Nobuaki Sato ,  Shinsuke Hirota ,  Takaaki Harada ,  Hikaru Yoshimura

IPC: C07D495/22 ,  C07D491/147 ,  C07D491/22

Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof: